Aimei Health Technology Co., Ltd (AFJK)
US — Financial Services Sector
Automate Your Wheel Strategy on AFJK
With Tiblio's Option Bot, you can configure your own wheel strategy including AFJK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol AFJK
- Rev/Share 0.2165
- Book/Share 6.804
- PB 1.6608
- Debt/Equity 0.0289
- CurrentRatio 0.0202
- ROIC -0.0243
- MktCap 69175583.0
- FreeCF/Share -0.1102
- PFCF -102.5073
- PE 38.4896
- Debt/Assets 0.0271
- DivYield 0
- ROE 0.0317
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About Aimei Health Technology Co., Ltd (AFJK)
- IPO Date
- Website None
- Industry Shell Companies
- CEO Junheng Xie
- Employees 2
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.